Cecily Q. Bernales

Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Clonal Hematopoiesis after 177Lu-PSMA-617 Radioligand Therapy in Prostate Cancer.

Clonal Hematopoiesis after 177Lu-PSMA-617 Radioligand Therapy in Prostate Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: December 01, 2025

Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancer.

Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancer.

Journal: Nature communications

Published: October 09, 2025

Repertoire and clinical hierarchy of AR locus alterations in castration-resistant prostate cancer.

Repertoire and clinical hierarchy of AR locus alterations in castration-resistant prostate cancer.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: June 26, 2025

Clonal hematopoiesis in metastatic urothelial and renal cell carcinoma.

Clonal hematopoiesis in metastatic urothelial and renal cell carcinoma.

Journal: NPJ precision oncology

Published: January 17, 2025

ERBB2/HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial Cancer.

ERBB2/HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 21, 2024

Plasma Cell-Free DNA Chromatin Immunoprecipitation Profiling Depicts Phenotypic and Clinical Heterogeneity in Advanced Prostate Cancer.

Plasma Cell-Free DNA Chromatin Immunoprecipitation Profiling Depicts Phenotypic and Clinical Heterogeneity in Advanced Prostate Cancer.

Journal: Cancer research

Published: June 20, 2024

Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer.

Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer.

Journal: Nature communications

Published: July 21, 2023

A generalizable machine learning framework for classifying DNA repair defects using ctDNA exomes.

A generalizable machine learning framework for classifying DNA repair defects using ctDNA exomes.

Journal: NPJ precision oncology

Published: November 12, 2022

Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotyping.

Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotyping.

Journal: Nature cancer

Published: September 30, 2022

Genomic Features of Lung-Recurrent Hormone-Sensitive Prostate Cancer.

Genomic Features of Lung-Recurrent Hormone-Sensitive Prostate Cancer.

Journal: JCO precision oncology

Published: May 04, 2022

Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer.

Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer.

Journal: Nature

Published: November 13, 2021

Genetic analysis of nucleotide-binding leucine-rich repeat (NLR) receptors in multiple sclerosis.

Genetic analysis of nucleotide-binding leucine-rich repeat (NLR) receptors in multiple sclerosis.

Journal: Immunogenetics

Published: April 29, 2020

Showing 1-12 of 33

Last Updated: 09/26/2026